# Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula

> **NCT06158659** · NA · COMPLETED · sponsor: **Heilongjiang Feihe Dairy Co. Ltd.** · enrollment: 240 (actual)

## Conditions studied

- Flu
- Cold

## Interventions

- **DIETARY_SUPPLEMENT:** Feihe Investigational Formula
- **DIETARY_SUPPLEMENT:** Control Formula
- **OTHER:** Breastfeeding

## Key facts

- **NCT ID:** NCT06158659
- **Lead sponsor:** Heilongjiang Feihe Dairy Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-14
- **Primary completion:** 2025-04-03
- **Final completion:** 2025-04-03
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06158659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06158659, "Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06158659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*